Post-Doctoral Research Fellow
Taiji Mizoguchi is a Research fellow investigating the efficacy of gene therapy for atherogenic dyslipidemia. He particularly focuses on in vivo genome editing technologies as tools to modify therapeutic target genes, which are associated with CVD. He graduated from Kobe University School of Medicine in 2008, thereafter finished his clinical practice in internal medicine and cardiology in Japan. He completed his Ph.D. work at Kobe University Graduate School of Medicine in 2017 under the guidance of Prof. Ken-ichi Hirata, investigating the effect of peripheral immune tolerance on atherosclerosis and wound healing after myocardial infarction. His research works are supported by an Uehara Memorial Foundation Research Fellowship.